Dopamine Transporter Density Profiles in Patients With Periodic Limb Movements
DOPATRANSPLM
1 other identifier
interventional
16
1 country
1
Brief Summary
Restless legs syndrome and periodic limb movement (PLM)are sleep-related movement disorders and studies have shown changes in striatal dopaminergic activity in patients with these disorders. Physical exercise has been shown to improve the symptoms of restless legs syndrome and PLM, as has treatment with dopamine agonists. However, the mechanism by which physical exercise acts as a non-pharmacological treatment in improving symptoms of restless legs syndrome and PLM remains unknown. The investigators evaluated dopamine transporter density profiles in 16 sedentary patients (control and experimental - with PLM, groups) and the influence of acute physical exercise on its concentration after a maximal exercise test. Each patient underwent baseline polysomnography to evaluate sleep patterns and PLM index values. After obtaining the polysomnography baseline, the single photon emission computer tomography baseline was determined. Subsequently, the volunteers performed a maximal exercise test in the morning, followed by a single photon emission computer tomography two hours later and polysomnography that night, to assess the effect of acute physical exercise on dopamine transporter and sleep patterns. The results showed significant lower dopamine transporter baseline densities in the striatum region for the experimental group. The results also showed a significant reduction in the periodic leg movement rate in the experimental group and a significant increased percentage of stage-1 non-REM sleep in both groups after maximal exercise test. Significant differences between the groups were only observed for Stage 2 sleep and slow wave sleep. Our results show that patients with PLM had a lower dopamine transporter density in the left putamen region compared to the control group and an acute physical exercise (maximal exercise test) did not alter this profile, providing evidence that this improvement is the result of chronic physical exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 16, 2011
CompletedFirst Posted
Study publicly available on registry
June 3, 2011
CompletedJune 3, 2011
May 1, 2011
1.6 years
May 16, 2011
June 2, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dopamine Transporter Density Measurement
Dopamine Transporter Density Measurement assessed by SPECT using TRODAT-1
Baseline and after 5 hours of exercise effort measurements
Secondary Outcomes (1)
Exercise Effort Maximum
1 week after baseline SPECT
Study Arms (2)
PLM group
ACTIVE COMPARATORIndividuals with increased periodic leg movement index (\>5)
Non-PLM group
ACTIVE COMPARATORIndividuals with PLM index \<5
Interventions
All individuals were submitted to physical exercise reaching maximum effort
Eligibility Criteria
You may qualify if:
- With and without PLM,
- no other health problems,
- sedentary
You may not qualify if:
- Other clinical and neurological conditions,
- continuous pharmacological treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro de Estudos em Psicobiologia e Exercicio
São Paulo, São Paulo, 04020-050, Brazil
Related Publications (3)
Earley CJ, Kuwabara H, Wong DF, Gamaldo C, Salas R, Brasic J, Ravert HT, Dannals RF, Allen RP. The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep. 2011 Mar 1;34(3):341-7. doi: 10.1093/sleep/34.3.341.
PMID: 21358851RESULTMrowka M, Jobges M, Berding G, Schimke N, Shing M, Odin P. Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome. J Neural Transm (Vienna). 2005 May;112(5):693-701. doi: 10.1007/s00702-004-0217-9. Epub 2004 Oct 27.
PMID: 15517434RESULTWetter TC, Eisensehr I, Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med. 2004 Jul;5(4):401-6. doi: 10.1016/j.sleep.2004.01.009.
PMID: 15223000RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marco Tulio Mello, PhD
Federal University of São Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 16, 2011
First Posted
June 3, 2011
Study Start
March 1, 2009
Primary Completion
October 1, 2010
Study Completion
December 1, 2010
Last Updated
June 3, 2011
Record last verified: 2011-05